Furthermore, shorter PSA doubling times and advanced tumor stages are predictive of metastatic spread, and these clinical characteristics should guide interpretation when evaluating rib uptake on PSMA PET/CT [163]. The gene discussed is FOLH1; the disease is neoplasm.